Nanoparticulate compositions of tubulin inhibitor

Details for Australian Patent Application No. 2005304952 (hide)

Owner Baxter International Inc. Baxter Healthcare S.A.

Inventors Kipp, James E.; Roessler, Berthold; Doty, Mark; Papadopoulos, Pavlos

Agent Peter Maxwell & Associates

Pub. Number AU-A-2005304952

PCT Pub. Number WO2006/052712

Priority 60/626,036 08.11.04 US; 60/642,878 11.01.05 US

Filing date 3 November 2005

Wipo publication date 18 May 2006

International Classifications

A61K 31/404 (2006.01)

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

10 May 2007 PCT application entered the National Phase

  PCT publication WO2006/052712 Priority application(s): WO2006/052712

31 May 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read Nanoparticulate compositions of tubulin inhibitors

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005304957-Glucuronide metabolites and epimers thereof of tigecycline

2005304950-4-Hydroxybenzomorphans